Antiovarian antibodies in primary Sjogren’s syndrome

被引:0
作者
Kyriaki Euthymiopoulou
Alexios J. Aletras
Panagiota Ravazoula
Anna Niarakis
Dimitris Daoussis
Ioannis Antonopoulos
Stamatis-Nick Liossis
Andrew P. Andonopoulos
机构
[1] University of Patras,Laboratory of Biochemistry, Department of Chemistry, School of Natural Sciences
[2] University of Patras,Department of Pathology, University Hospital of Patras, School of Medicine
[3] University of Patras,Division of Rheumatology of the Department of Medicine, School of Medicine
来源
Rheumatology International | 2007年 / 27卷
关键词
Antiovarian antibodies; Sjogren’s syndrome; Autoimmune oophoritis; Premature ovarian failure;
D O I
暂无
中图分类号
学科分类号
摘要
Our study aimed at screening patients with primary Sjogren’s syndrome (pSs) for the presence of antiovarian antibodies (AOAs). Detection of AOAs in patients’ sera was achieved by ELISA, using bovine ovarian extract for coating. Western blot analysis and immunohistochemistry were used to characterize the antibody targets in the extract and to determine their locus on the bovine ovary, respectively. Specific AOAs were detected in 27% of 37 patients (two with premature menopause) and in none of the controls. Immunoreactivity mainly resided in five proteins of the extract with molecular masses 42, 49, 55, 64 and 72 kDa, and it might be attributed to their carbohydrate components. The antibody targets were mainly located in the granulosa and theca interna cells of the follicle, and in the endothelial cells and fibroblasts of corpus luteum. The detection, for the first time, of AOAs in a significant percentage of patients with pSs may suggest autoimmune oophoritis, clinical or subclinical.
引用
收藏
页码:1149 / 1155
页数:6
相关论文
共 50 条
[21]   Sex differences in primary Sjogren's syndrome [J].
Brennan, MT ;
Fox, PC .
JOURNAL OF RHEUMATOLOGY, 1999, 26 (11) :2373-2376
[22]   Primary Sjogren's Syndrome Complicated by Sarcoidosis [J].
Tokuyasu, Hirokazu ;
Harada, Tomoya ;
Touge, Hirokazu ;
Kawasaki, Yuji ;
Maeda, Ryo ;
Isowa, Noritaka ;
Ohnuma, Hideyuki ;
Miura, Hiroshi ;
Shimizu, Eiji .
INTERNAL MEDICINE, 2008, 47 (23) :2049-2052
[23]   Emerging drugs for primary Sjogren's syndrome [J].
Gandolfo, Saviana ;
De Vita, Salvatore .
EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (02) :121-132
[24]   Rituximab Therapy in Primary Sjogren's Syndrome [J].
Alcantara, Cristina ;
Gomes, Maria Joao ;
Ferreira, Carlos .
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 :701-705
[25]   Lmmunogenetics of primary Sjogren's syndrome in Colombians [J].
Anaya, JM ;
Mantilla, RD ;
Correa, PA .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 34 (05) :735-743
[26]   Pulmonary Manifestations of Primary Sjogren's Syndrome [J].
Parke, Ann L. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2008, 34 (04) :907-+
[27]   The assessment of fatigue in primary Sjogren's syndrome [J].
Lwin, CTT ;
Bishay, M ;
Platts, RG ;
Booth, DA ;
Bowman, SJ .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2003, 32 (01) :33-37
[28]   Ischemic choroidopathy in primary Sjogren's syndrome [J].
Rapoport, P ;
Merle, H ;
Smadja, D .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 1998, 76 (05) :627-628
[29]   Mycophenolate for the treatment of primary Sjogren's syndrome [J].
Chen, Weiqian ;
Lin, Jin .
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2020, 8 (03) :146-149
[30]   Primary Sjogren's Syndrome and Cardiovascular Disease [J].
Melissaropoulos, Konstantinos ;
Bogdanos, Dimitrios ;
Dimitroulas, Theodoros ;
Sakkas, Lazaros, I ;
Kitas, George D. ;
Daoussis, Dimitrios .
CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (05) :447-454